Skip to main content

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

NIHR launched a funding call concerning ambitious data-enabled "e-trials" in England

On July 25, 2024, the National Institute for Health and Care Research (NIHR) launched a funding call within the HTA Programme concerning ambitious data-enabled trial proposals (or “e-trials”) that can use routine data sources for key trial processes, such as patient identification, intervention delivery and for collecting outcomes in an efficient way. 

Proposed interventions need to be mature enough to be tested on a national scale. The program is particularly interested in ambitious studies that use data-enabled approaches at scale.

The first-stage application deadline is November 27, 2024. Successful applicants will then be invited to submit a second-stage application. The second-stage applications will be considered at the Funding Committee in May 2025.

See the full details here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.